Conditional Support Signals Path Forward
The Medicines and Healthcare products Regulatory Agency reports broad public and stakeholder support for adopting AI in health services across the UK, but that support is conditional. Patients, clinicians and industry respondents consistently said they would accept AI tools only when there is clear evidence of safety, demonstrable clinical effectiveness, strong data protections and ongoing monitoring once products are in use.
Balancing Innovation with Safeguards
The MHRA emphasises a risk based approach that lets lower risk tools reach practice more quickly while requiring stricter controls for higher risk applications. Experts including Professor Alastair Denniston and Lawrence Tallon stress the need for proportionate rules that do not stifle development but do protect patients. Practical measures flagged include premarket validation, transparent evidence dossiers, registries for post-market performance and clear accountability for failures.
AI as a Clinical Support Tool
Across submissions there was a clear preference for AI to augment clinical decision-making rather than replace clinicians in high-stakes scenarios. Respondents highlighted the importance of human oversight, explainability of AI outputs and clinician training so that AI recommendations can be interpreted and challenged when necessary. Trust depends on clinicians retaining final responsibility and on systems that surface uncertainty in algorithmic advice.
Informing Future UK AI Policy
The MHRA findings will feed into the National Commission into the Regulation of AI in Healthcare as it prepares recommendations. For developers this means building robust evidence packages and planning for ongoing monitoring. For health providers it means updating procurement, governance and consent processes. For policymakers the challenge is to create a predictable, risk sensitive regulatory pathway that supports innovation while keeping patient safety front of mind.
These conclusions give a clear signal: the UK public will accept more AI in healthcare, but only with systems in place that prove and maintain safety and effectiveness over time.
